Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07729514 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Different Hyaluronic Acids in the Treatment of Subdeltoid Bursitis

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Interventions: high molecular hyaluronic acid injection (Drug), ultra-high molecular weigth hyaluronic acid injection (Drug) to high molecular weight hyaluronic acid injection (Drug), ultra-high molecular weight hyaluronic acid injection (Drug)
    • Eligibility criteria expanded, about 1 word
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study employs a double-blind, randomized clinical trial design with 50 patients diagnosed with subdeltoid bursitis. Participants are divided into two groups: ultra-high-molecular-weight hyaluronic acid or high-molecular-weight hyaluronic acid injection. All injections are guided by ultrasound. Assessments are conducted before treatment and at 1 week, 1 month, and 3 months post-treatment.
Trial Details
NCT Number NCT07729514
Lead Sponsor Shin Kong Wu Ho-Su Memorial Hospital
Conditions
(from sponsor)		 Subdeltoid Bursitis of the Shoulder
Related terms Pain
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov